Ipamorelin vs Tesamorelin
Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Ipamorelin and Tesamorelin (also searched as Tesamorelin vs Ipamorelin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Ipamorelin centers on metabolic, while Tesamorelin leans toward metabolic. On indexed research, Tesamorelin is ahead (Ipamorelin: 6 studies, Human evidence; Tesamorelin: 14, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Ipamorelin is strongest for metabolic; Tesamorelin for metabolic.
- •Evidence: Ipamorelin Human evidence (6 studies) vs Tesamorelin Human clinical (14).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Growth Hormone Secretagogue | Selective GHRP
GHRH analog | Reduces visceral fat in HIV lipodystrophy
Ipamorelin vs Tesamorelin: side-by-side
| Metric | Ipamorelin | Tesamorelin |
|---|---|---|
| Class | GH | Metabolic |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Human clinical |
| Studies indexed | 6 | 14 |
| Research level | Well Studied | FDA Approved |
| Strongest effect | Metabolic & appetite | Metabolic & appetite |
| Healing & recovery | 2.0▲ | 1.0 |
| Muscle & body comp | 3.0▲ | 2.0 |
| Metabolic & appetite | 3.0 | 5.0▲ |
| Neuro & mood | 2.0▲ | 2.0▲ |
| Sleep & circadian | 1.0▲ | 1.0▲ |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 2.0 | 3.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Ipamorelin | Tesamorelin |
|---|---|---|
| Mechanism | Selective GH secretagogue / ghrelin-receptor agonist | GHRH analog |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~2 h | ~26–38 min |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Ipamorelin?
Ipamorelin is a synthetic peptide that acts as a selective agonist of the growth hormone secretagogue receptor, primarily stimulating growth hormone release. Its potential therapeutic applications are being explored in various contexts, including weight management and pain modulation.
Full Ipamorelin profile, mechanism & studies →What is Tesamorelin?
Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It is primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution often exacerbated by antiretroviral therapy. Tesamorelin stimulates the release of endogenous growth hormone, which in turn promotes lipolysis and reduces visceral adipose tissue (VAT) accumulation.
Full Tesamorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Ipamorelin | 2.0/5 effect signal |
| Muscle | Ipamorelin | 3.0/5 effect signal |
| Metabolic | Tesamorelin | 5.0/5 effect signal |
| Neuro | Even | Both ~2.0/5 |
| Sleep | Even | Both ~1.0/5 |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Tesamorelin | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Ipamorelin and Tesamorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Ipamorelin vs Tesamorelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Ipamorelin has 6 approved studies indexed (Human evidence), and Tesamorelin has 14 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Ipamorelin or Tesamorelin better?
It depends on your goal. Ipamorelin is strongest for metabolic; Tesamorelin for metabolic. Tesamorelin has more indexed studies (14). See the goal-by-goal breakdown above.
Is Ipamorelin or Tesamorelin better for weight loss?
Tesamorelin shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Ipamorelin or Tesamorelin better for muscle?
Ipamorelin leads on the muscle & body-composition axis (3.0/5).
Which has more research, Ipamorelin or Tesamorelin?
Ipamorelin has 6 approved studies indexed (Human evidence); Tesamorelin has 14 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Ipamorelin and Tesamorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Ipamorelin vs Tesamorelin?
Ipamorelin: no community-reported effects logged yet. Tesamorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Ipamorelin or Tesamorelin FDA-approved?
Ipamorelin is a research-use compound and is not FDA-approved. Tesamorelin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Tesamorelin better than Ipamorelin?
For metabolic, Tesamorelin has the edge; for metabolic, Ipamorelin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.